Name: | Description: | Size: | Format: | |
---|---|---|---|---|
369.74 KB | Adobe PDF |
Advisor(s)
Abstract(s)
Mitochondrial dysfunction is involved in a number of chronic
neurodegenerative disorders. Acetyl-L-carnitine (ALC) has been proposed to confer
effective neuroprotection by increasing mitochondria viability, but little is known
regarding the molecular mechanisms involved in its action